Deferred Income Tax Liabilities, Net of WINDTREE THERAPEUTICS INC /DE/ from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
WINDTREE THERAPEUTICS INC /DE/ quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • WINDTREE THERAPEUTICS INC /DE/ Deferred Income Tax Liabilities, Net for the quarter ending 30 Sep 2025 was $1,643,000, a 66% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,643,000 -$3,244,000 -66% 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 $5,075,000 +$303,000 +6.4% 30 Jun 2025 10-Q 19 Aug 2025 2025 Q2
Q1 2025 $4,643,000 -$216,000 -4.4% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $4,528,000 -$530,000 -10% 31 Dec 2024 10-Q 19 Nov 2025 2025 Q3
Q3 2024 $4,887,000 +$74,000 +1.5% 30 Sep 2024 10-Q 26 Nov 2024 2024 Q3
Q2 2024 $4,772,000 -$208,000 -4.2% 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 $4,859,000 -$222,000 -4.4% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $5,058,000 -$3,000 -0.06% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $4,813,000 -$1,382,000 -22% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $4,980,000 -$1,663,000 -25% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $5,081,000 -$1,804,000 -26% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $5,061,000 -$2,053,000 -29% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 $6,195,000 -$2,512,000 -29% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $6,643,000 -$2,031,000 -23% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $6,885,000 -$9,798,000 -59% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $7,114,000 -$9,664,000 -58% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $8,707,000 -$7,663,000 -47% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $8,674,000 -$7,455,000 -46% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $16,683,000 +$924,000 +5.9% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $16,778,000 +$957,000 +6% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $16,370,000 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $16,129,000 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $15,759,000 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 $15,821,000 +$345,000 +2.2% 31 Dec 2019 10-K 29 Mar 2021 2020 FY
Q4 2018 $15,476,000 31 Dec 2018 10-K 03 Apr 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.